BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11474137)

  • 21. Zn II(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism.
    McAllum EJ; Roberts BR; Hickey JL; Dang TN; Grubman A; Donnelly PS; Liddell JR; White AR; Crouch PJ
    Neurobiol Dis; 2015 Sep; 81():20-4. PubMed ID: 25766674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminoglycoside ototoxicity in three murine strains and effects on NKCC1 of stria vascularis.
    Chu HQ; Xiong H; Zhou XQ; Han F; Wu ZG; Zhang P; Huang XW; Cui YH
    Chin Med J (Engl); 2006 Jun; 119(12):980-5. PubMed ID: 16805980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of hearing loss in kanamycin treated chinchillas.
    Ryan A; McGee TJ
    Ann Otol Rhinol Laryngol; 1977; 86(2 pt. 1):176-82. PubMed ID: 848827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Galangin prevents aminoglycoside-induced ototoxicity by decreasing mitochondrial production of reactive oxygen species in mouse cochlear cultures.
    Kim YR; Kim MA; Cho HJ; Oh SK; Lee IK; Kim UK; Lee KY
    Toxicol Lett; 2016 Mar; 245():78-85. PubMed ID: 26778349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation.
    Fang J; Wu H; Zhang J; Mao S; Shi H; Yu D; Chen Z; Su K; Xing Y; Dong H; Shi H
    Biomed Pharmacother; 2022 Jun; 150():113071. PubMed ID: 35658237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of TMPRSS3 in the rat cochlea following kanamycin ototoxicity].
    Peng A; Ge S; Wang Q; Xie D; Wu W; Xiao Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 36(10):987-91. PubMed ID: 22086001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disparities in auditory physiology and pathology between C57BL/6J and C57BL/6N substrains.
    Kendall A; Schacht J
    Hear Res; 2014 Dec; 318():18-22. PubMed ID: 25456090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperthermia increases aminoglycoside ototoxicity.
    Henry KR; Guess MB; Chole RA
    Acta Otolaryngol; 1983; 95(3-4):323-7. PubMed ID: 6837286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Simple Model for Inducing Optimal Increase of
    Ju HM; Lee SH; Choi JS; Seo YJ
    Biomed Res Int; 2017; 2017():4630241. PubMed ID: 29430461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aminoglycoside ototoxicity.
    Bates DE
    Drugs Today (Barc); 2003 Apr; 39(4):277-85. PubMed ID: 12743643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Audiometric and histopathologic evaluation of ototoxicity of 3',4'-dideoxykanamycin B, a new aminoglycoside antibiotic (author's transl)].
    Akiyoshi M; Sato K; Nakada H; Tajima T
    Jpn J Antibiot; 1974 Feb; 27(1):15-26. PubMed ID: 4546334
    [No Abstract]   [Full Text] [Related]  

  • 33. Aminoglycoside cochlear ototoxicity.
    Matz GJ
    Otolaryngol Clin North Am; 1993 Oct; 26(5):705-12. PubMed ID: 8233484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adeno-associated virus-mediated Bcl-xL prevents aminoglycoside-induced hearing loss in mice.
    Liu YH; Ke XM; Qin Y; Gu ZP; Xiao SF
    Chin Med J (Engl); 2007 Jul; 120(14):1236-40. PubMed ID: 17697574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vestibulometry in prognosis of lesions of the organ of hearing after administration of aminoglycoside antibiotics].
    Bazarov VG; Mishchanchuk NS
    Zh Ushn Nos Gorl Bolezn; 1978; (6):21-7. PubMed ID: 216180
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of protective agents against cisplatin ototoxicity.
    Rybak LP; Husain K; Morris C; Whitworth C; Somani S
    Am J Otol; 2000 Jul; 21(4):513-20. PubMed ID: 10912697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of antioxidants and other agents to prevent cisplatin ototoxicity.
    Rybak LP; Whitworth C; Somani S
    Laryngoscope; 1999 Nov; 109(11):1740-4. PubMed ID: 10569399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circadian rhythm dependent kanamycin-induced hearing loss in rodents assessed by auditory brainstem responses.
    Yonovitz A; Fisch JE
    Acta Otolaryngol; 1991; 111(6):1006-12. PubMed ID: 1763620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevation of superoxide dismutase increases acoustic trauma from noise exposure.
    Endo T; Nakagawa T; Iguchi F; Kita T; Okano T; Sha SH; Schacht J; Shiga A; Kim TS; Ito J
    Free Radic Biol Med; 2005 Feb; 38(4):492-8. PubMed ID: 15649651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ototoxicity of some drug agents].
    Iaroshevich VI
    Voen Med Zh; 1975 Oct; (10):31-4. PubMed ID: 54985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.